MabThera er indiceret til behandling af tidligere ubehandlede patienter med stadium III- IV follikulært lymfom i kombination med kemoterapi.
MabThera is indicated for the treatment of previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy.